SHANGHAI, China, Feb. 5 /Xinhua-PRNewswire/ -- China-Biotics, Inc. (“China-Biotics”, “the Company”), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced the third quarter fiscal 2008 earnings conference call previously scheduled for Tuesday, February 5, 2008, will be held at 9 a.m. EST on Wednesday, February 13, 2008.
To participate in the event by telephone, please dial (888) 241-0558 five to 10 minutes prior to the start time (to allow time for registration) and reference the conference ID 33078994. International callers should dial (647) 427-3417.
A digital replay of the call will be available on Wednesday, February 13 at approximately 11:00 a.m. EST through Wednesday, February 20 at midnight EST. To listen to the replay, dial (800) 839-4177 and enter the conference ID number 33078994. International callers should dial (402) 220-2901 and enter the same conference ID number.
The conference call will also be webcast live over the Internet and can be accessed by all interested parties at the company’s Web site, http://www.chn-biotics.com .
To monitor the live webcast, please go to this web site at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. An audio replay of the event will be archived on China-Biotics’ Web site at http://www.chn-biotics.com/ for 90 days.
About China-Biotics, Inc.
Headquartered in Shanghai, China-Biotics, Inc. (“China-Biotics”, “the Company”) was founded in 1999 and is one of China’s largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company’s product portfolio contains live microbials made with proprietary technology. Currently, these products are sold over-the-counter under the “Shining” brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China and will launch 300 Shining brand logistic centers in these cities during the next two years. The Company’s flagship product, “Shining Essence”, has been a profit driver since its launch in April 2001. There is a significant demand for probiotics for use in the bulk additive market, which is currently met by imports. China-Biotics is building a new plant which will increase its production capacity manifolds to capture this market. For more information, please visit http://www.chn-biotics.com .
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company’s ability to market existing and new products, ability to access to capital for expansion, and changes from anticipated levels of sales, future national or regional economic and competitive conditions, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.
crocker.coulson@ccgir.com
CONTACT: Crocker Coulson, President of CCG Elite Investor Relations, +1-
646-213-1915 (New York), or crocker.coulson@ccgir.com
Web site: http://www.chn-biotics.com/
